Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 76 clinical trials
Featured trial
Respiratory Syncytial Virus (RSV) Vaccine

The study will enroll up to 23,000 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and …

vaccination
  • 0 views
  • 18 Oct, 2021
  • 1 location
Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Adults 18 Years of Age and Older.

(Adenovirus Type 5 Vector) in adults 18 years of age and older, living with HIV, on stable treatment, and virologically suppressed for at least 6 months Protocol number: FH-58

  • 0 views
  • 01 Oct, 2021
  • 4 locations
Antibody Response to COVID-19 Vaccines in Liver Disease Patients

Currently the Pfizer-Biontech (mRNA), Sinovac (inactivated virus) and Astrazeneca-Oxford (adenovirus-vector) COVID-19 vaccines are available for vaccination in HK. The American Association of

  • 0 views
  • 31 May, 2021
  • 1 location
Arbidol for COPD Exacerbations

viruses including respiratory syncytial disease (RSV), parainfluenza virus, human rhinovirus, coxsackie virus (CV), adenovirus (ADV) and so on. In recent years, some fundamental and clinical researches

  • 0 views
  • 23 Jan, 2021
  • 1 location
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

variety of viruses including CMV, EBV, BK and adenovirus. We hypothesize that SARS-CoV-2 specific CTLs generated from a previously infected family donor will be safe and effective for treatment of COVID

  • 0 views
  • 17 Jan, 2022
  • 1 location
Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen

, without age limit, on March 11, 2021. Janssen's vaccine is a viral non replicating vector (adenovirus) vaccine targeting the Spike protein of the SARS-CoV-2 virus. It differs from currently available

Accepts healthy volunteers
  • 27 views
  • 02 Dec, 2021
  • 10 locations
Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis Post HSCT

after stem cell infusion) has been associated with reactivation of viruses, including cytomegalovirus, polyoma BK and JC viruses, and adenovirus types I and II. Former studies have confirmed that the

cell transplantation
acute graft-versus-host disease
hematologic disorders
graft versus host disease
hemorrhagic cystitis
  • 1 views
  • 18 Sep, 2021
  • 1 location
Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

The purpose of this clinical trial is to evaluate the effectiveness and safety of oncolytic viruses H101 intra-tumor injection combined with or without radiotherapy in refractory or recurrent gynecological malignancies. And further research the mechanism of oncolytic viruses H101.

  • 0 views
  • 17 Oct, 2021
  • 1 location
Factors Influencing the COVID-19 Vaccine Immune Response According to Age and Presence or Not of a Past History of COVID-19

Age is the main risk factor associated with the severity of COVID-19. From the beginning of the vaccination campaign, elderly subjects are part of the priority population. However, immunosenescence appears to play a role in the natural post-COVID-19 immunity of convalescent elderly subjects and also in the post-vaccination response. However, …

Accepts healthy volunteers
  • 0 views
  • 24 Nov, 2021
  • 3 locations
Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer

The use of chemoradiotherapy (CRT), in combination with surgery is the standard of care in the treatment of locally advanced rectal cancer. However some patients don't respond well to radiation. More advanced radiotherapy techniques, that result in fewer toxicities, means that we are now able to combine new anti-cancer agents …

  • 5 views
  • 24 Jan, 2021
  • 1 location